but they mentioned a lot of things in their report that are questionable in my opinion. like they said there could be delays if there is an issue with funding and raising money. they also stressed multiple time that they are basically running out of cash, are in debt, have taken a loan from cosmo but still to go through with the trial they need even more cash from private investors. the worry is that this gets stuck in the pipeline for more years because that funding will not come in.
they did also say "phase 3 trial could be 6 months vs 1 year" which is great but they also said "IF the 12 month results are good" but as they are writing this, shouldn't they be aware already of whether the results are good? the trial ended 5 weeks ago
anyway my biggest worry is that they will run very tight financially-and their strategy, I mean the market is not that great to start with and their price suggesting of 85$, I would assume a lot of people will stick with finasteride if it works for them because we have generics there. 1k$ a year is really not something the average joe will spend on a hair loss product that is just a tad better than finasteride. so this all in one might turn into a big financial flop, before and after market release. the data would have to be really good to justify that pricing